NEW YORK (GenomeWeb) – Genome mapping company BioNano Genomics said in a regulatory filing that it raised $5 million toward a targeted $6.1 million financing round.

In a document filed with the US Securities and Exchange Commission last week, BioNano said that the type of securities offered included debt; option, warrant, or other rights to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.